Trial intelligence / Profile preview

Albuterol vs Levalbuterol Oxygen Consumption in Healthy Volunteers

NCT02802111Completed

Sponsor
Children's Hospital Los Angeles
Start
Jun 2015
Primary completion
Sep 2017
Modality
Small Molecules
01

Overview

Randomised, single-blind trial of levalbuterol in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Children's Hospital Los Angeles. Primary endpoint: Oxygen Consumption. Started Jun 2015; status: completed.

02

Drugs

levalbuterol
03

Conditions

asthmachronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02802111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02802111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call